Holen Sie sich die Stockscreener-App
28.68
0.95%
0.27
Handel nachbörslich:
28.68
Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
99.81%
0.132
|
70.57 | 0.075 | 0.072 | 0.086 |
| Operating Expenses |
11.12%
122.88
|
110.58 | 106.84 | 93.94 | 83.57 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
11.12%
122.88
|
110.58 | 106.84 | 93.94 | 83.57 |
| Operating Income/Loss |
206.77%
-122.75
|
-40.01 | -106.77 | -93.87 | -83.48 |
| Nonoperating Income/Loss |
55.78%
2.394
|
5.414 | 6.032 | 6.954 | 6.791 |
| Income/Loss From Continuing Operations Before Tax |
99.81%
0.132
|
70.57 | -100.73 | -86.91 | 0.086 |
| Income/Loss From Continuing Operations After Tax |
247.86%
-120.36
|
-34.60 | -100.73 | -86.91 | -76.69 |
Net Income/Loss
|
247.86%
-120.36
|
-34.60 | -100.73 | -86.91 | -76.69 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):